Balyasny Asset Management
TBPH icon

Balyasny Asset Management’s Theravance Biopharma TBPH Stock Holding History

Balyasny Asset Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,098
Closed -$293K – 3584
2025
Q3 		$293K Buy
+20,098
New +$254K ﹤0.01% 2587
2024
Q3 		– Sell
-34,107
Closed -$289K – 3198
2024
Q2 		$289K Buy
34,107
+2,822
+9% +$25.5K ﹤0.01% 2239
2024
Q1 		$281K Buy
+31,285
New +$290K ﹤0.01% 2285
2023
Q4 		– Sell
-13,699
Closed -$118K – 2919
2023
Q3 		$118K Buy
+13,699
New +$132K ﹤0.01% 2109
2018
Q2 		– Sell
-65,149
Closed -$1.58M – 2163
2018
Q1 		$1.58M Sell
65,149
-23,543
-27% -$647K 0.01% 1063
2017
Q4 		$2.47M Sell
88,692
-91,908
-51% -$2.72M 0.01% 1080
2017
Q3 		$6.18M Buy
180,600
+24,850
+16% +$813K 0.03% 647
2017
Q2 		$6.21M Sell
155,750
-61,674
-28% -$2.37M 0.03% 695
2017
Q1 		$8.01M Buy
217,424
+35,059
+19% +$1.12M 0.04% 569
2016
Q4 		$5.81M Buy
+182,365
New +$5.66M 0.04% 650

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return